PAPER Okie S

Confronting Alzheimer's disease.

N Engl J Med. 2011 Sep 22;365(12):1069-72. PubMed: 21992119

PAPER Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.

J Neurochem. 2011 Dec;119(6):1330-40. PubMed: 21992552

PAPER Henderson ST, Poirier J

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study.

BMC Med Genet. 2011;12:137. PubMed: 21992747

PAPER Sorribas A, Jiménez JI, Yoshida WY, Williams PG

Daedalols A-C, fungal-derived BACE1 inhibitors.

Bioorg Med Chem. 2011 Nov 15;19(22):6581-6. PubMed: 21992804

PAPER Zhang D, Shen D,

Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease.

Neuroimage. 2012 Jan 16;59(2):895-907. PubMed: 21992749

PAPER Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L

S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.

Pharmacol Biochem Behav. 2012 Jan;100(3):361-9. Epub 2011 Oct 2 PubMed: 21993310

PAPER McGlinchey RP, Yap TL, Lee JC

The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17.

Phys Chem Chem Phys. 2011 Dec 7;13(45):20066-75. PubMed: 21993592

PAPER Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M

Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition.

J Neurosci. 2011 Oct 12;31(41):14488-95. PubMed: 21994365

PAPER Raivio MM, Laakkonen ML, Pitkälä KH

Alzheimer's patients' spouses critiques of the support services.

ISRN Nurs. 2011;2011:943059. PubMed: 21994898

PAPER Geekiyanage H, Chan C

MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease.

J Neurosci. 2011 Oct 12;31(41):14820-30. PubMed: 21994399

PAPER Montgomery RJ, Kwak J, Kosloski K, O'Connell Valuch K

Effects of the TCARE® intervention on caregiver burden and depressive symptoms: preliminary findings from a randomized controlled study.

J Gerontol B Psychol Sci Soc Sci. 2011 Sep;66(5):640-7. PubMed: 21840840

PAPER Barber R

Inflammatory signaling in Alzheimer disease and depression.

Cleve Clin J Med. 2011 Aug;78 Suppl 1:S47-9. PubMed: 21972331

PAPER Wint D

Depression: a shared risk factor for cardiovascular and Alzheimer disease.

Cleve Clin J Med. 2011 Aug;78 Suppl 1:S44-6. PubMed: 21972330

PAPER Grammas P, Sanchez A, Tripathy D, Luo E, Martinez J

Vascular signaling abnormalities in Alzheimer disease.

Cleve Clin J Med. 2011 Aug;78 Suppl 1:S50-3. PubMed: 21972332

Toward a New Research Agenda in Alzheimer’s Disease

CONFERENCE COVERAGE SERIES From Australia, Impulse for a New Alzheimer’s Research Agenda Australia Report: Genetics and Aging Australia Report: Protein Aggregation, Selective Vulnerability, Spreading Australia Report: Aβ Toxicity, ApoE Australia Report: Inflammation Australia Repor